From: Roles of eIF3m in the tumorigenesis of triple negative breast cancer
Author | Subtypes (sample) | P-value | Fold change |
---|---|---|---|
Curtis | IBC vs. Breast (21 vs. 144) | 4.30E − 6 | 1.801 |
BPT vs. Breast (5 vs. 144) | 0.008 | 1.828 | |
TBC vs. Breast (67 vs. 144) | 7.17E − 14 | 1.922 | |
IDLBC vs. Breast (90 vs. 144) | 2.87E − 12 | 1.844 | |
IDBC vs. Breast (1556 vs. 144) | 7.49E − 16 | 1.442 | |
BC vs. Breast (14 vs. 144) | 0.024 | 1.284 | |
MBC1 vs. Breast (46 vs. 144) | 6.08E − 8 | 1.635 | |
DBCS vs. Breast (10 vs. 144) | 0.005 | 1.412 | |
MBC2 vs. Breast (32 vs. 144) | 3.24E − 4 | 1.593 | |
ILBC vs. Breast (148 vs. 144) | 4.64E − 7 | 1.338 | |
BBN vs. Breast (3 vs. 144) | 0.057 | 1.437 | |
Sorlie | DBC vs. Breast (92 vs. 4) | 0.037 | 1.169 |
Ma | IDBC vs. Breast (9 vs. 14) | 0.016 | 1.102 |
Richardson | DBC vs. Breast (40 vs. 7) | 0.002 | 1.182 |
TCGA | IDBC vs. Breast (639 vs. 111) | 9.24E − 5 | 1.030 |